Company Filing History:
Years Active: 2011-2012
Title: Morris Pollard: Innovator in Tissue Vaccines
Introduction
Morris Pollard is a notable inventor based in Mishawaka, IN (US). He has made significant contributions to the field of medical research, particularly in the development of tissue vaccines aimed at combating cancer. With a total of 2 patents, his work focuses on innovative solutions for tumor treatment.
Latest Patents
Pollard's latest patents include groundbreaking compositions for tissue vaccines. These vaccines comprise a mixture of heterogeneous tissue obtained from tumors and connective tissues. The patents detail methods for using these vaccines in the treatment and inhibition of tumor growth, specifically targeting prostate tumors and cancers. The preparations are defined as vaccines that include tumor cells and connective (stromal) tissues derived from xenogeneic animals. His research also discloses methods for preventing the de novo development of cancer. Notably, a tissue vaccine comprising glutaraldehyde-(GFT) treated tissue has been shown to reduce the incidence of autochthonous prostate cancer. Additionally, a potassium thiocyanate extract (PTE) preparation of tumor and connective tissue is provided, demonstrating efficacy in reducing cancer incidence.
Career Highlights
Morris Pollard is affiliated with the University of Notre Dame Du Lac, where he continues to advance his research in the field of cancer treatment. His innovative work has garnered attention and respect within the scientific community.
Collaborations
Pollard has collaborated with esteemed colleagues such as Mark A Suckow and William R Wolter, contributing to the advancement of research in tissue vaccines and cancer treatment.
Conclusion
Morris Pollard's contributions to the field of tissue vaccines represent a significant advancement in cancer treatment methodologies. His innovative patents and ongoing research continue to pave the way for new therapeutic options in oncology.